[Federal Register Volume 62, Number 5 (Wednesday, January 8, 1997)]
[Notices]
[Page 1127]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-328]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
Heart, Lung, and Blood Special Emphasis Panel (SEP) meeting:
Name of SEP: Tuberculosis Academic Award Review.
Date: January 28, 1997.
Time: 9:00 a.m.
Place: Chevy Chase Holiday Inn, 5520 Wisconsin Avenue, Chevy
Chase, Maryland 20815.
Contact Person: Louise P. Corman, Ph.D., Two Rockledge Center,
Room 7180, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0270.
Purpose/Agenda: To review and evaluate grant applications.
Name of SEP: Reference Laboratory to Evaluate Therapies for
Sickle Cell Disease (Telephone Conference Call).
Date: February 26, 1997.
Time: 1:30 p.m.
Place: Rockledge Building II, Room 7214, 6701 Rockledge Drive,
Bethesda, Maryland 20892.
Contact Person: Diane M. Reid, M.D., Two Rockledge Center, Room
7182, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0277.
Purpose/Agenda: To review and evaluate grant applications.
Name of SEP: Molecular Genetics of Coagulation Disorders.
Date: February 26-27, 1997.
Time: 7:30 p.m.
Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda,
Maryland 20814.
Contact Person: Louis M. Ouellette, Ph. D., Two Rockledge
Center, Room 7216, 6701 Rockledge Driver, Bethesda, MD 20892-7924,
(301) 435-0310.
Purpose/Agenda: To review and evaluate grant applications.
Name of SEP: Hepatic Gene Therapy for Hemophilia B.
Date: February 27-28, 1997.
Time: 7:30 p.m.
Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda,
Maryland 20814.
Contact Person: Louis M. Ouellette, Ph.D., Two Rockledge Center,
Room 7216, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0310.
Purpose/Agenda: To review and evaluate grant applications.
These meetings will be closed in accordance with the provisions set
forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart
and Vascular Diseases Research; 93.838, Lung Diseases Research; and
93.839, Blood Diseases and Resources Research, National Institutes
of Health)
Dated: December 30, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 97-328 Filed 1-7-97; 8:45 am]
BILLING CODE 4140-01-M
